Compound Glossary

USP-grade sterile water preserved with 0.9% benzyl alcohol that inhibits bacterial growth, enabling multi-dose use for up to 28 days after initial puncture of the vial seal.

A stable pentadecapeptide (15 amino acids) derived from human gastric juice Body Protection Compound. Uniquely stable without a carrier in acidic environments, extensively studied for cytoprotective and regenerative properties.

A synergistic combination of two repair peptides: BPC-157 (gastric pentadecapeptide) and TB-500 (Thymosin Beta-4 fragment), providing complementary tissue repair pathways.

A long-acting acylated amylin analog that activates amylin and calcitonin receptors, providing sustained appetite suppression and metabolic regulation with weekly dosing potential.

A combination of a GHRH analog (CJC-1295 Mod GRF) and a GHRP (Ipamorelin) that work through complementary receptor pathways to produce amplified, synergistic growth hormone release.

A modified fragment of GHRH consisting of the first 29 amino acids with four amino acid substitutions to resist enzymatic degradation, producing pulsatile GH release with a ~30-minute half-life.

A nonapeptide originally isolated from rabbit cerebral venous blood during induced sleep, modulating sleep architecture and showing stress-protective and neuroendocrine regulatory properties.

A synthetic tetrapeptide analog of epithalamin, the natural pineal gland peptide. It activates telomerase reverse transcriptase (hTERT) to maintain telomere length in dividing cells.

Glycyl-L-histidyl-L-lysine copper(II) complex, a naturally occurring tripeptide with strong affinity for copper(II) ions. Found in human plasma at ~200ng/mL in youth, declining significantly with age.

A multi-peptide blend combining GHK-Cu (copper peptide), TB-500 (Thymosin Beta-4), and BPC-157 for synergistic skin remodeling, tissue repair, and rejuvenation research.

A tripeptide (γ-glutamylcysteinylglycine) that serves as the primary intracellular antioxidant and detoxification agent, maintaining redox homeostasis and supporting immune function.

A selective pentapeptide growth hormone secretagogue that acts on the ghrelin receptor (GHS-R1a) to stimulate GH release with high selectivity, showing minimal effects on ACTH, cortisol, or prolactin.

A four-component peptide blend (BPC-157, GHK-Cu, TB-500, KPV) designed for comprehensive multi-pathway tissue repair, anti-inflammatory, and skin rejuvenation research.

The C-terminal tripeptide (Lys-Pro-Val) of α-MSH that retains anti-inflammatory properties independent of classical melanocortin receptor activation, acting primarily through NF-κB inhibition.

A multi-component lipolytic solution combining riboflavin for fat oxidation, lecithin for cell membrane disruption, and bromelain for anti-inflammatory support in fat dissolution research.

A synthetic tridecapeptide analog of α-MSH with enhanced stability and selective MC1R agonist activity, stimulating eumelanin production for photoprotection research.

A cyclic heptapeptide analog of α-MSH with broad melanocortin receptor activity (MC1R, MC3R, MC4R, MC5R), studied for melanogenesis and multiple melanocortin-mediated physiological pathways.

A multi-component peptide complex targeting skin rejuvenation through complementary mechanisms including collagen stimulation, antioxidant protection, and cellular repair signaling.

Nicotinamide Adenine Dinucleotide in its oxidized form, a universal cellular coenzyme essential for redox reactions, sirtuin activation, PARP-mediated DNA repair, and CD38 signaling.

A cyclic heptapeptide melanocortin agonist derived from Melanotan 2, with primary activity at MC4R in the CNS. Unlike PDE5 inhibitors, it acts through central melanocortin pathways.

A triple-acting receptor agonist that simultaneously targets GIP, GLP-1, and glucagon receptors, providing multi-pathway metabolic modulation beyond dual-agonist approaches.

A synthetic heptapeptide derived from tuftsin with a stabilizing Gly-Pro extension, exhibiting anxiolytic activity comparable to benzodiazepines without sedation or addiction potential in research models.

A synthetic ACTH(4-7) analog with Pro-Gly-Pro extension that provides neuroprotective and cognitive-enhancing effects in research without adrenocorticotropic hormonal activity.

The biologically active N-terminal 29-amino acid fragment of endogenous GHRH(1-44). It retains full GHRH receptor agonist activity and stimulates physiological GH release with intact negative feedback.

A cell-permeable, mitochondria-targeted tetrapeptide (D-Arg-Dmt-Lys-Phe-NH2) that binds cardiolipin on the inner mitochondrial membrane to optimize electron transport chain function.

A synthetic peptide representing the active region of Thymosin Beta-4, a 43-amino acid actin-sequestering protein involved in cell motility, angiogenesis, and wound healing.

A full-length GHRH(1-44) analog with a trans-3-hexenoic acid modification providing enhanced stability. It is the only GHRH analog with extensive clinical research in lipodystrophy models.

A first-in-class dual GIP and GLP-1 receptor agonist (twincretin), a 39-amino acid peptide with biased agonism at both incretin receptors and a C20 fatty diacid for extended duration of action.